Two years after forging an alliance with Applied DNA Sciences (APDN) on a DNA taggant platform for tablets and capsules, Colorcon has formally launched the technology.

The specialist in pharmaceutical excipients has developed a version of its Opadry film coating technology that incorporates APDN’s SigNature DNA markers and can be used to “significantly reduce the risks associated with counterfeit and falsified medications entering the supply chain.”

In December 2017, Colorcon and APDN announced they were working together on incorporating the taggants into “film coating systems, inks and colour dispersions for use in solid oral dosage forms,” and this is the first commercial offering to come out of that partnership.